CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals (Nasdaq: IDRA) today announced Robert W. Karr, M.D., President, has resigned from his full-time management position at the Company effective December 31st, 2007. He will remain a member of the Company’s Board of Directors and has entered into a consulting agreement with the Company.
